N° 6422 – 5 rabii I 1437 (17-12-2015) BULLETIN OFFICIEL 4487
DÉNOMINATION COMMUNE INTERNATIONALE | DOSAGE | FORME D'ADMINISTRATION
ANTINEOPLASIQUES ET IMMUNOMODULATEURS
ANTINEOPLASIQUES CYTOTOXIQUES
Asparaginase | 10 000 U | Injectable Bleomycine | 15 mg | Injectable Bevacizumab | 100 mg | Injectable Bevacizumab | 400 mg | Injectable Chlorambucil | 2 mg | Orale Cisplatine | 10 mg | Injectable Cisplatine | 25 mg | Injectable Cisplatine | 50 mg | Injectable Cyclophosphamide | 50 mg | Orale Cyclophosphamide | 200 mg | Injectable Cyclophosphamide | 500 mg | Injectable Cyclophosphamide | 1 g | Injectable Daunorubicine | 20 mg | Injectable Doxorubicine | 10 mg | Injectable Doxorubicine | 50 mg | Injectable Etoposide | 50 mg | Orale Etoposide | 20 mg | Injectable Etoposide | 100 mg | Injectable Epirubicine | 10 mg | Injectable Epirubicine | 50 mg | Injectable Estramustine | 140 mg | Orale 5-Fluorouracil | 250 mg | Injectable 5-Fluorouracil | 500 mg | Injectable Fludarabine | 10 mg | Orale Folinate de calcium | 25 mg | Injectable Folinate de calcium | 50 mg | Injectable Folinate de calcium | 100 mg | Injectable